Welcome to LookChem.com Sign In|Join Free
  • or
Trifluoro-acetaldehyde-(2,4-dinitro-phenylhydrazone) is a complex organic compound with the chemical formula C8H5F3N4O4. It is derived from the reaction of trifluoroacetaldehyde with 2,4-dinitrophenylhydrazine, resulting in the formation of a hydrazone derivative. trifluoro-acetaldehyde-(2,4-dinitro-phenylhydrazone) is characterized by the presence of three fluorine atoms attached to the acetaldehyde moiety and a 2,4-dinitrophenylhydrazone group, which is a conjugate base of 2,4-dinitrophenylhydrazine. Trifluoro-acetaldehyde-(2,4-dinitro-phenylhydrazone) is often used in chemical research and analysis due to its unique properties and reactivity, and it can be employed as a reagent or intermediate in the synthesis of various organic compounds.

323-01-3

Post Buying Request

323-01-3 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

323-01-3 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 323-01-3 includes 6 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 3 digits, 3,2 and 3 respectively; the second part has 2 digits, 0 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 323-01:
(5*3)+(4*2)+(3*3)+(2*0)+(1*1)=33
33 % 10 = 3
So 323-01-3 is a valid CAS Registry Number.

323-01-3Downstream Products

323-01-3Relevant academic research and scientific papers

DRUG ADHERENCE MONITORING SYSTEM

-

Page/Page column 64, (2010/11/28)

The present invention provides novel methods for monitoring subject adherence in taking prescribed drugs by detecting markers in exhaled breath after a subject takes the prescribed drug. In particular, the present invention provides novel methods for making additives that are combined with the drug(s). Upon biological breakdown of the drug/additive formulation in a subject's body, markers resulting directly from the biological breakdown of the additives are detected in exhaled breath using sensor technology. In certain embodiments of the invention, the drug adherence monitoring systems and methods include a reporting system capable of tracking subject compliance (either remotely or proximately) and of providing necessary alerts to the subject, caregiver, healthcare provider, and the like.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 323-01-3